| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 494.97M | 513.81M | 560.72M | 582.27M | 488.05M |
| Gross Profit | 80.30M | 222.02M | 240.81M | 247.87M | 224.80M |
| EBITDA | 47.91M | 36.79M | 60.13M | 70.15M | 62.34M |
| Net Income | 9.93M | 4.44M | 20.89M | 33.82M | 26.86M |
Balance Sheet | |||||
| Total Assets | 451.19M | 433.32M | 468.96M | 473.91M | 449.54M |
| Cash, Cash Equivalents and Short-Term Investments | 35.09M | 39.45M | 34.46M | 36.25M | 57.71M |
| Total Debt | 96.84M | 74.88M | 105.08M | 94.99M | 95.61M |
| Total Liabilities | 178.57M | 163.23M | 191.31M | 199.21M | 193.80M |
| Stockholders Equity | 267.50M | 264.35M | 271.72M | 264.60M | 243.27M |
Cash Flow | |||||
| Free Cash Flow | -5.49M | 42.93M | 14.69M | -1.81M | 43.80M |
| Operating Cash Flow | 6.31M | 51.21M | 32.18M | 10.69M | 51.70M |
| Investing Cash Flow | -18.96M | -6.33M | -21.75M | -10.41M | -31.99M |
| Financing Cash Flow | 16.28M | -47.47M | -12.21M | -21.88M | -11.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | €146.98M | 20.18 | 8.29% | 1.82% | -41.38% | -28.83% | |
73 Outperform | €206.54M | 6.69 | 11.18% | 1.56% | -1.40% | 15.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | €151.75M | 12.73 | 3.74% | 0.69% | -3.31% | 134.05% | |
55 Neutral | €504.63M | -5.24 | -21.53% | ― | -12.83% | -372.97% | |
55 Neutral | €161.67M | -30.71 | -2.41% | ― | -8.60% | -107.57% | |
48 Neutral | €146.41M | -1.21 | -4.16% | ― | 2.91% | 76.47% |